04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Female Employee Physically and Verbally Harassed By Supervisors, Federal Agency Charged - DALLAS - ...
Read More >
JLL Partners has announced it has acquired MedeAnalytics. MedeAnalytics, based in Richardson, Texas...
Read More >
Investment funds may face enhanced premerger reporting requirements under a new rule jointly propose...
Read More >
California passed a sweeping new privacy law that will impact many businesses. The California Consum...
Read More >
On October 29, 2019, Chancellor Andre G. Bouchard of the Delaware Court of Chancery granted partial ...
Read More >
M&A in the US oil and gas sector faced significant headwinds in 2019, even before the COVID-19 pande...
Read More >